(S)-2-(4-((3-(1-(Hydroxyamino)-4-methyl-1-oxopentan-2-yl)ureido)methyl)-1H-1,2,3-triazol-1-yl)benzyl 2-methoxybenzoate

ID: ALA4472945

Chembl Id: CHEMBL4472945

PubChem CID: 155535841

Max Phase: Preclinical

Molecular Formula: C25H30N6O6

Molecular Weight: 510.55

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccccc1C(=O)OCc1ccccc1-n1cc(CNC(=O)N[C@@H](CC(C)C)C(=O)NO)nn1

Standard InChI:  InChI=1S/C25H30N6O6/c1-16(2)12-20(23(32)29-35)27-25(34)26-13-18-14-31(30-28-18)21-10-6-4-8-17(21)15-37-24(33)19-9-5-7-11-22(19)36-3/h4-11,14,16,20,35H,12-13,15H2,1-3H3,(H,29,32)(H2,26,27,34)/t20-/m0/s1

Standard InChI Key:  DUUIIYSIDUKKQO-FQEVSTJZSA-N

Alternative Forms

  1. Parent:

    ALA4472945

    ---

Associated Targets(Human)

ANPEP Tchem Aminopeptidase N (863 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

ANPEP Aminopeptidase N (1645 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 510.55Molecular Weight (Monoisotopic): 510.2227AlogP: 2.35#Rotatable Bonds: 11
Polar Surface Area: 156.70Molecular Species: NEUTRALHBA: 9HBD: 4
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 8.72CX Basic pKa: CX LogP: 2.66CX LogD: 2.64
Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.17Np Likeness Score: -1.14

References

1. Cao J, Zang J, Kong X, Zhao C, Chen T, Ran Y, Dong H, Xu W, Zhang Y..  (2019)  Leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry. Part II.,  27  (6): [PMID:30737134] [10.1016/j.bmc.2019.01.041]

Source